Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.
Biogen Idec to acquire Fumapharm AG; Consolidates ownership of oral compound BG-12 being studied for multiple sclerosis
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
A New Colour Reaction on Copper and Certain Carbonyl Compounds
Oral BG-12 (dimethyl fumarate) significantly reduced multiple sclerosis (MS) relapses and disability progression in DEFINE Phase 3 clinical trial
MS clinical trials: what can subgroup analyses teach us?
Extracellular Cues Influencing Oligodendrocyte Differentiation and (Re)myelination.
SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination.
Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?
MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study.
Comparative efficacy of interferon β versus glatiramer acetate for relapsing-remitting multiple sclerosis.
MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study.
Masitinib mesylate application for conditional approval
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex (SYNERGY)
In vitro and in vivo pharmacological models to assess demyelination and remyelination.
Delayed visual evoked response in optic neuritis.
Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation.
Meta-analysis of adverse events in recent randomized clinical trials for dimethil fumarate, glatiramer acetate and teriflunomide for the treatment of relapsing forms of multiple sclerosis.
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis.
Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β1a in Relapsing-Remitting Multiple Sclerosis.
Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis.

Pages